IP management, Technology Transfer (Licencing, Spin-out company establishment & investment) in Health Science, Pharmacy, Biotech & Medtech.Following equity holding Spin-out companies: Ankere Therapeutics (Board Observer); Brandon BioCatalyst/IPGroup, Cincera Therapeutics (Board Observer); Brandon BioCatalyst, MPI Biotech (Managing Director), DesmoX (Managing Director), AbRegen (previous Management Consultant/Board/Capital), Ferronova (previous Capital raise), Envision Sciences (IP), Carina Biotech.Supporting: IP Management for the 'Centre for Cancer Biology' and previously support of the 'Future Industries Institute' www.unisa.edu.au/ventures

Hospira was acquired by Pfizer in 2015Pharmaceutical Manufacture - 'Biosimilars' with One to One Contract Manufacture.# I was also involved managing teams from Quality (Validation), Production & Engineering as part of the site upgrade project. Cross functional dealings included construction project team, Quality Systems and Manufacturing Quality.

Consulting Activities:Contracting R&D Tax Project Manager - ROCG Perth (Insight Business Partners) - May 2014 to Jan 2015.> $3 Million R&D Tax Offsets to clients. Experienced in Overseas and Advanced Findings; > $8 Million Successful R&D spend approvals. Clients from Oil & Gas, software to Industrial Design amongst many.OzStar Therapeutics - WA Investment and Market Support - Commercialisation Australia Proof of concept grant - $250kan Agribusiness - Dairy Business technologies and ProductsBiologica VenturesVarious Peptide Technologies

A contract services & R&D company focusing on analysis of Biosimilar & Biologic Drugs and protein Biomarkers. My roles include International Business Development (including managing sales teams in India, Singapore, Malaysia and Japan), Commercialisation, Project Management (eg. Biomarker Diagnostics), IP Management.I recently played a significant role in PI's successful Early Stage Commercialisation grant from Commercialisation Australia to develop a test in Diabetic Kidney Disease (Nephropathy)http://www.commercialisationaustralia.gov.au/OurParticipants/Pages/Proteomics%20International%20Pty%20Ltd.aspx'PromarkerD' - world leading predictive diagnostic test for diabetic kidney disease

Phylogica is an Australian ASX listed Biotech. As a peptide Drug Discovery Company Phylogica uses phage display to screen diverse in-house peptide libraries against medically relevant targets.My roles: Peptide Drug Discovery/Validation and Preclinical Drug Development

Technical Consultant to Beckman Coulter in Australia.Presales support; Site commissioning of Microcal (ITC,DSC); Equipment validation; Technical Training and follow-up support.